Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early

Heekyong R Bae1,2, Su-Kyung Shin1,2, Ji-Yoon Lee1,2

  • 1Department of Food Science and Nutrition, Kyungpook National University, Daegu 41566, Republic of Korea.

Insights

Chronic low-level interferon-gamma (IFN-γ) disrupts mitochondrial complex I in macrophages, contributing to autoimmune diseases like lupus nephritis. This dysfunction is reversible, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Mitochondrial Biology
  • Autoimmune Disease Pathogenesis

Background:

  • Mitochondrial dysfunction and macrophage dysregulation are key in autoimmune diseases.
  • The precise mechanisms linking these factors, especially chronic low-level interferon-gamma (IFN-γ), are not fully understood.

Purpose of the Study:

  • To investigate the role of sustained low-level IFN-γ in autoimmune pathogenesis.
  • To elucidate the connection between IFN-γ, mitochondrial dysfunction, and macrophage behavior in lupus nephritis.

Main Methods:

  • Utilized ARE-Del mice with chronic low-level IFN-γ expression and lupus nephritis (LN)-like symptoms.
  • Performed age- and tissue-dependent gene expression analysis, focusing on mitochondrial complex I.
  • Examined macrophage function and mitochondrial complex I activity in renal macrophages.

Main Results:

  • Significant suppression of mitochondrial complex I components and activity was observed in ARE-Del mice kidneys.
  • This suppression of mitochondrial complex I preceded and contributed to macrophage dysfunction.
  • Remission in lupus-prone mice correlated with restored mitochondrial complex I and macrophage function.

Conclusions:

  • Chronic low-level IFN-γ disrupts mitochondrial complex I activity in macrophages, a critical early step in autoimmune disease pathogenesis.
  • This study identifies a novel molecular link between IFN-γ signaling and mitochondrial health in macrophages.
  • Findings suggest targeting IFN-γ-mediated mitochondrial disruption as a potential therapeutic strategy for autoimmune diseases like lupus nephritis.